A

Advanced ENT and Allergy | Breckenridge

Research site

(Unclaimed)

Location

2944 Breckenridge Lane, Louisville, Kentucky, United States of America

Site insights

Top conditions

Top treatments

Mometasone furoate

GB001

PRV211

PRV111

OTO-313

AD109

Omalizumab

Mometasone Furoate

Miconazole

Dupilumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 21 total trials

A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)

Post-market study to continue to evaluate the effectiveness of the RhinAer ARC Stylus for chronic rhinitis.

Active, not recruiting

Chronic Rhinitis

Device: RhinAer ARC Stylus

EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients (EVEREST)

Primary Objective-To evaluate the efficacy of dupilumab compared to omalizumab in reducing the polyp size and improving sense of smellSecondary Objec...

Active, not recruiting

Asthma

Chronic Rhinosinusitis With Nasal Polyps

Drug: Omalizumab

Drug: Placebo

Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...

Enrolling

OSA

Drug: Placebo

Drug: AD109

Safety and Efficacy Study of PRV211 in Subjects With Oral Squamous Cell Carcinoma

PRV211 is a sterilized nano engineered delivery system intended for intraoperative chemotherapy treatment for all solid tumor surgeries immediately f...

Enrolling

Oral Squamous Cell Carcinoma

Drug: PRV211 (Intraoperative Cisplatin System)